Inventor
OKARMA THOMAS B
US15 patents
⚠️ This page may combine multiple inventors who share the name “OKARMA THOMAS B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
APPLIED IMMUNESCIENCES
8 patentsUS5354678AOct 11, 1994
Production of recombinant adeno-associated virus vectors
APPLIED IMMUNESCIENCES219 citations98
US5173414ADec 22, 1992
Production of recombinant adeno-associated virus vectors
APPLIED IMMUNESCIENCES1,269 citations98
US5523096AJun 4, 1996
Removal of selected factors from whole blood or its components
APPLIED IMMUNESCIENCES111 citations95
US5437861AAug 1, 1995
Removal of selected factors from whole blood or its components; and prevention and treatment of septic shock syndrome
APPLIED IMMUNESCIENCES67 citations94
US5283034AFeb 1, 1994
Stabilization of sterilized surfaces for research and medical use
APPLIED IMMUNESCIENCES63 citations89
US5022988AJun 11, 1991
Device for plasma modification--composition and remodeling
APPLIED IMMUNESCIENCES14 citations73
US4963265AOct 16, 1990
Plasma processing device with anaphylatoxin remover
APPLIED IMMUNESCIENCES15 citations73
US5317088AMay 31, 1994
C-terminal conglutinin fragments coupled to solid support
APPLIED IMMUNESCIENCES1 citations51
RHONE POULENC RORER PHARMA
6 patentsUS5691176ANov 25, 1997
Recombinant adeno-associated virus vector packaging cells and methods for use
RHONE POULENC RORER PHARMA193 citations98
US5589377ADec 31, 1996
Recombinant adeno-associated virus vectors
RHONE POULENC RORER PHARMA121 citations98
US5780280AJul 14, 1998
Recombinant adeno-associated virus vectors
RHONE POULENC RORER PHARMA40 citations95
US5681731AOct 28, 1997
Method for producing recombinant adeno-associated virus vectors
RHONE POULENC RORER PHARMA51 citations95
US5730713AMar 24, 1998
Removal of selected factors from whole blood or its components
RHONE POULENC RORER PHARMA91 citations94
US6143508ANov 7, 2000
Device and process for cell capture and recovery
RHONE POULENC RORER PHARMA18 citations84